Suppr超能文献

2002年至2022年肝纤维化的文献计量学与可视化分析

A bibliometric and visualized analysis of liver fibrosis from 2002 to 2022.

作者信息

Zhao Qianqian, Liang Luhua, Zhai Fei, Ling Guixia, Xiang Rongwu, Jiang Xiwei

机构信息

Faculty of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, 110016, China.

School of Medical Equipment, Shenyang Pharmaceutical University, Shenyang, 110016, China.

出版信息

J Gastroenterol Hepatol. 2023 Mar;38(3):359-369. doi: 10.1111/jgh.16081. Epub 2022 Dec 12.

Abstract

Fibrosis of the liver is a degenerative alteration that occurs in the majority of chronic liver disorders. Further progression can lead to cirrhosis, liver failure, and hepatocellular carcinoma, which can seriously affect the health and lives of patients. The field of liver fibrosis research has flourished in the last 20 years, with approximately 9000 articles retrieved from the Web of Science Core Collection database alone. In order to identify future research hotspots and potential paths in a thorough and scientifically reliable manner, it is important to organize and visualize the research on this topic from a holistic and very general perspective. This study used bibliometric analysis with CiteSpace and VOSviewer software to provide a quantitative analysis, hotspot mining, and commentary of articles published in the field of liver fibrosis over the last 20 years. This bibliometric analysis contains a total of 8994 articles with 45667 authors from 6872 institutions in 97 countries, published in 1371 journals and citing 156 309 references. The literature volume has steadily increased over the last 20 years. Research has focused on gastroenterology and hepatology, pharmacology and pharmacy, and medicine, research, and experimental areas. We found that the pathological mechanisms, diagnostic and quantitative methods, etiology, and antifibrotic strategies constitute the knowledge structure of liver fibrosis. Finding mechanisms for liver fibrosis regression, identifying precise noninvasive diagnostic and prognostic biomarkers, and creating efficient liver fibrosis patient treatments are the main goals of current research.

摘要

肝纤维化是大多数慢性肝脏疾病中出现的一种退行性改变。病情进一步发展可导致肝硬化、肝衰竭和肝细胞癌,严重影响患者的健康和生命。在过去20年里,肝纤维化研究领域蓬勃发展,仅从科学引文索引核心合集数据库就检索到约9000篇文章。为了全面、科学可靠地识别未来的研究热点和潜在路径,从整体和宏观的角度对该主题的研究进行整理和可视化非常重要。本研究使用CiteSpace和VOSviewer软件进行文献计量分析,对过去20年发表在肝纤维化领域的文章进行定量分析、热点挖掘和评论。这项文献计量分析共包含8994篇文章,来自97个国家6872个机构的45667名作者,发表在1371种期刊上,引用参考文献156309篇。在过去20年里,文献数量稳步增长。研究集中在胃肠病学与肝病学、药理学与药剂学以及医学研究与实验领域。我们发现,病理机制、诊断和定量方法、病因以及抗纤维化策略构成了肝纤维化的知识结构。寻找肝纤维化消退的机制、识别精确的非侵入性诊断和预后生物标志物以及开发有效的肝纤维化患者治疗方法是当前研究的主要目标。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验